Biote (BTMD) EBIT (2021 - 2026)

Biote (BTMD) has reported EBIT for 6 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT fell 67.33% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $1.4 million (up 361.26% YoY), while the FY2025 annual figure was $7.9 million, up 3605.63% from the prior year.
• EBIT came in at $3.2 million for Q1 2026 at Biote, up from -$20.8 million in the prior quarter.
• The five-year high for EBIT was $68.4 million in Q4 2022, with the low at -$85.6 million in Q2 2022.
• Average EBIT over 5 years is $2.4 million, with a median of $7.8 million recorded in 2022.
• The largest YoY upside for EBIT was 9150.29% in 2022 against a maximum downside of 934.34% in 2022.
• Year by year, EBIT stood at $68.4 million in 2022, then tumbled by 91.95% to $5.5 million in 2023, then tumbled by 619.81% to -$28.6 million in 2024, then rose by 27.25% to -$20.8 million in 2025, then soared by 115.2% to $3.2 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $3.2 million, -$20.8 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.